Thus, pre-treatment SEPTIN9 gene methylation ratio correlates with tumor size and N stage and can predict tumor response to total neoadjuvant therapy in patients with locally advanced rectal cancer. This evidence concerns the gene SEPTIN9 and rectal cancer.